Poland· PL-100127105
Pedea
A ibuprofen product containing ibuprofenum, registered in Poland by Recordati Rare Diseases. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ibuprofen is registered in 10 of 19 countries.
Countries holding a registration under ATC C01EB16 (ibuprofen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Ibuprofen · ATC C01EB16
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Ibuprofenum
- Manufacturer
- Recordati Rare Diseases
- Country
- Poland (PL)
- ATC code
- C01EB16
- ATC class
- Ibuprofen
- Defined daily dose
- 30 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990008131
- gtin03663502000694
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
805 interactions on record for ibuprofen.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ibuprofen · interactions on record
805 records
- 71 severe
- 306 moderate
- 15 minor
- 413 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01EB16
Ibuprofen, as other registers publish it.
- IcelandIbuprofen Gen.OrphGen.Orph
- PolandIbuprofen Gen.OrphGen.Orph
- DenmarkIbuprofen Gen.OrphGen.Orph SaS
- FinlandIbuprofen Gen.OrphGEN.ORPH
- CzechiaIBUPROFEN GEN.ORPHGen.Orph, Saint Cloud
- BelgiumIbuprofen Gen.Orph 5 mg/mlGen-Orph
- IrelandIbuprofen Gen.Orph 5 mg/mL solution for injectionGen.Orph
- NetherlandsIbuprofen Gen.Orph 5 mg/ml-oplossing voor injectieGen-Orph SaS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b560b86d-53a4-4917-aea7-9d36c43abad1 GET /v1/drugs/b560b86d-53a4-4917-aea7-9d36c43abad1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "5 mg/ml",
"packaging": "05909990008131 ¦ Rpz ¦ EU/1/04/284/001 ¦ 24210\n4 amp. 2 ml\n03663502000694 ¦ Rpz ¦ EU/1/04/284/001 ¦ 160637\n4 amp. 2 ml",
"substance": null,
"common_name": "Ibuprofenum",
"pl_product_id": "100127105",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about ibuprofen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.